The CURE High Drug Prices Act would permit HHS to force pharmaceutical firms to pay back increases in drug prices to payers and other consumers if the agency deems a price hike is excessive, or bring back the drug's old price for a certain period under qualified or federal health plans.
Bill seeks to block drug price hikes deemed excessive
Sign up for BIO SmartBrief
Biotechnology industry news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.